[1] LEENEN FH,YUAN B.Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin Ⅱ type 1 receptor blockade[J].Hypertension,2001,37(3):981
[2] CHEN GF,WAGNER L,MSAAAER JM,et al.Effects of angiotensintype 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats[J].Nephrol Dial Transplant,2010,25(11):3518
[3] 魏兆丽,高爱滨,崔玉英.厄贝沙坦与氨氯地平治疗2 型糖尿病合并高血压的临床研究[J].中国临床药理学杂志,2013,29(2):86
WEI ZL,GAO AB,CUI YY.The clinical study of irbesartan and amlodipine for the treatment of type 2 diabetes combined with hypertension[J].Chin J Clin Pharmacol,2013,29(2):86
[4] 黄震华. 血管紧张素Ⅱ受体拮抗药厄贝沙坦在高血压治疗中的应用[J].中国新药与临床杂志,2007,26(5):384
HUANG ZH.Application of angiotensin Ⅱ receptor antagonist irbesartan in treatment of hypertension[J].Chin J New Drugs Clin Rem,2007,26(5):384
[5] 谭业蕙,黄齐亮.常用4种抗高血压药治疗原发性高血压的成本效果分析[J].中国医院用药评价与分析,2012,12(3):241
TAN YH,HUANG QL.Cost-effectiveness analysis of four commonly used antihypertensive drugs for essential hypertension[J].Eval Anal Drug Use Hosp China,2012,12(3):241
[6] 吴逢波,占美,唐尧.厄贝沙坦治疗高血压合并高尿酸血症疗效和安全性的系统评价[J].中国循证医学杂志,2011,11(11):1290
WU FB,ZHAN M,TANG Y.Irbesartan for hypertensive patients with hyperuricaemia:a systematic review[J].Chin J Evid Base Med,2011,11(11):1290
[7] 李锦清,罗旦朝,李宁,等.厄贝沙坦片的制备工艺与溶出度一致性研究[J].药物评价研究,2017,40(5):600
LI JQ,LUO DZ,LI N,et al.Preparation of irbesartan tablets and consistency study of their dissolubility[J].Drug Eval Res,2017,40(5):600
[8] 武峰,赵秀丽,崔艳丽,等.动态血压监测厄贝沙坦治疗高血压的临床疗效[J].中国医院药学杂志,2006,26(10):1220
WU F,ZHAO XL,CUI YL,et al.The clinical effect of irbesartan on hypertension assessed by ambulatory blood pressure monitoring[J].Chin Hosp Pharm J,2006,26(10):1220
[9] 丁跃有,张维忠,蔡凯愉,等.血管紧张素Ⅱ受体拮抗剂对高血压患者动脉弹性及脉压的影响[J].上海医学,2006,29(9):636
DING YY,ZHANG WZ,CAI KY,et al.Clinical study of irbesartan on improving arterial elasticity and pulse pressure in essential hypertensives[J].Shanghai Med J,2006,29(9):636
[10] 赵湘,邱莲女,郭俊华,等.厄贝沙坦对血管紧张素Ⅱ介导的大鼠肾小球系膜细胞增殖的影响[J].浙江医学,2007,29(12):1262
ZHAO X,QIU LN,GUO JH,et al.The effect of irbesartan on proliferation of mesangial cells induced by angiotensin Ⅱ in rats[J].Zhejiang Med J,2007,29(12):1262
[11] 华丛笑,华潞,李娜,等.动态血压监测15种单药治疗原发性高血压的降压疗效[J].中国科学医学院学报,2007,29(6):792
HUA CX,HUA L,LI N,et al.Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring[J].Chin Med Sci J,2007,29(6):792
[12] 黄巧巧,何佳佳,钟乃飞,等.柱切换离子色谱法测定厄贝沙坦中的叠氮根离子[J].药物分析杂志,2013,33(8):1431
HUANG QQ,HE JJ,ZHONG NF,et al.Determination of azide ion in irbesartan by column-switching ion chromatography[J].Chin J Pharm Anal,2013,33(8):1431
[13] 徐文峰,金鹏飞,徐硕,等.LC-Q-TOF-MS 法测定氯沙坦钾及其复方制剂中痕量杂质N-亚硝基-N-甲基-4-氨基丁酸[J].药物分析杂志,2019,39(11):2047
XU WF,JIN PF,XU S,et al.Determination of trace impurity NMBA in potassium losartan and its compound preparations by LCQ-TOF-MS[J].Chin J Pharm Anal,2019,39(11):2047
[14] 蔡鲁峰,李娜,杜莎,等.N-亚硝基化合物的危害及其在体内外合成和抑制的研究进展[J].食品科学,2016,37(5):271
CAI LF,LI N,DU SH,et al.Progress in hazards,synthesis and inhibition of N-nitroso compounds in vitro and in vivo[J].Food Sci,2016,37(5):271
[15] 幸苑娜,王欣,陈泽勇,等.气球中N-亚硝胺及其前体物迁移量的测定与NDMA的儿童致癌暴露风险分析[J].分析测试学报,2012,31(7):779
XING YN,WANG X,CHEN ZY,et al.Determination of migration levels of N-nitrosamines and N-nitrosatable substances in balloons and carcinogenic risk exposure level of NDMA in balloon to children[J].J Instrum Anal,2012,31(7):779
[16] 陈非. 吹扫捕集-气相色谱质谱联用法测定水中N-亚硝基二甲胺[J].化学工程师,2018,273(6):28
CHEN F.Determination of N-nitroso two methylamine in water by prge and trap gaschromatography mass spectrometry[J].Chem Eng,2018,273(6):28
[17] 杨荣静,卫碧文,高欢,等.气相色谱-正化学电离质谱法检测婴儿奶嘴中N-亚硝胺物质的迁移量[J].理化检验-化学分册,2013,49(12):1423
YANG RJ,WEI BW,GAO H,et al.GC-MS(PCI)determination of N-nitrosamines migrated from infant nipple[J].Phys Test Chem Anal(Part B:Chem Anal),2013,49(12):1423
[18] 何书海,曹小聪,李腾崖,等.全自动固相萃取-气相色谱-串联质谱法测定水质中N-亚硝胺类化合物[J].环境化学,2019,38(5):1197
HE SH,CAO XC,LI TY,et al.Determination of nine N-nitrosamines in water by gas chromatographytandem mass spectrometry with auto-solid phase extraction[J].Environ Chem,2019,38(5):1197
[19] 简龙海,孟茜,陈丹丹,等.液相色谱-大气压化学离子化-串联质谱法测定化妆品中8种亚硝胺[J].香料香精化妆品,2015,8(4):59
JIAN LH,MENG Q,CHEN DD,et al.Determination of eight nitrosamines in cosmetics by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry[J].Flavour Frag Cosmet,2015,8(4):59
[20] 宋更申,周丽,徐艳梅,等.UPLC-ESI-MS/MS 法测定八子补肾胶囊中14种成分的含量[J].药学学报,2016,51(5):792
SONG GS,ZHOU L,XU YM,et al.Determination of 14 components in Bazibushen capsule by UPLC-ESI-MS/MS[J].Acta Pharm Sin,2016,51(5):792
[21] 闫凯,徐艳梅,徐敬朴,等.UPLC-MS/MS 法测定积雪草中7种有效成分的含量[J].中国临床药理学杂志,2017,33(19):1949
YAN K,XU YM,XU JP,et al.Determination of seven active components in Centellaasiatica by UPLC-MS/MS[J].Chin J Clin Pharmacol,2017,33(19):1949
